BioFocus DPI launches ‘Intelligent Screening’ platform at SBS

BioFocus DPI is launching a new approach to discovery biology at the Society for Biomolecular Sciences Annual Conference taking place this week in St. Louis. Called ‘Intelligent Screening’, this approach focuses on combining the know-how and expertise of BioFocus DPI’s scientists with extensive high-throughput and information-rich screening capabilities to generate faster results and accelerate partners’ drug discovery programs.

According to Dr. Katherine Hilyard, Vice President of Biological Sciences at BioFocus DPI: “As the name Intelligent Screening implies, we are promoting an intelligence-led approach to discovery biology. This means harnessing our considerable screening experience within a wide range of target classes and disease areas to develop customized, biologically-relevant assays for partners’ discovery programs. This is in contrast with alternative approaches such as running numerous high-volume, high-throughput tests where the likelihood of identifying compounds with the desired biological activity is low.”

In shaping its Intelligent Screening approach, BioFocus DPI calls upon: PrimePath™, its compound screening service that uses disease-relevant complex assays in human primary cells; its high-throughput and information-rich ion channel screening capabilities; and its natural product screening platform, which is ideal for addressing difficult targets, such as protein-protein interactions. Furthermore, these services are complemented by BioFocus DPI’s world-class screening libraries.

More information about using this Intelligent Screening approach in hit finding, hit-to-lead and lead optimization campaigns can be found via the article webpage.